Pharmerica (PMC) Reports In-Line Q2 EPS
News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.
Pharmerica (NYSE: PMC) reported Q2 EPS of $0.47, in-line with the analyst estimate of $0.47. Revenue for the quarter came in at $519.6 million versus the consensus estimate of $508.31 million.Pharmerica reaffirmed FY2016 guidance.
For earnings history and earnings-related data on Pharmerica (PMC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Boston Properties (BXP) Reports In-Line Q3 FFO, Guides Above the Street
- First Commonwealth Financial (FCF) Tops Q3 EPS by 2c
- Logitech (LOGI) Tops Q2 EPS by 10c
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!